Previous 10 | Next 10 |
NEWS RELEASE 13 FEBR UARY 202 3 , 4:00PM ET / 22:00 CET UnitedHealthcare singles out mdxheath’s GPS test as its only commercially-covered test to risk stratify men newly diagnosed with localized prostate cancer IRVIN...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: William Potter / Shutterstock.com Gaucho Group (NASDAQ: VINO ) stock is falling hard on Friday after the e-commerce company announced a new $44 million equity line of credit (ELOC) yesterday. With yester...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: metamorworks / Shutterstock MDxHealth (NASDAQ: MDXH ) stock is falling on Friday after the healthcare company revealed plans for a proposed public stock offering . With this offering, MDxHealth is seeking...
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET MDxHealth Announces Pricing of Offering of ADSs in the United States IRVINE, CA, and HERSTAL, BELGIUM – February 3, 2023 – MDxHealth SA (NASDAQ/...
MDxHealth ( NASDAQ: MDXH ) is offering $40M of ADS , each of which represents ten ordinary shares. On January 31, 2023, the last sale price of our ADSs as reported on the Nasdaq Capital Market was $6.67 per ADS. For further details see: MDxHealth announces $40M ADS offering
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 1, 2023, 4PM ET/ 22:00 CET MDxHealth Announces Launch of Offering of ADSs in the United States IRVINE, CA, and HERSTAL, BELGIUM –February 1, 2023 – MDxHealth SA (NASDAQ/Euronext...
NEWS RELEASE – REGULATED INF O RMATION 20 JANUARY 202 3 , 1 : 0 0 a m ET / 7 : 0 0 am CET MDxHealth Provides Update d and Supplemental Financial Information ...
NEWS RELEASE – INSIDE AND REGULATED INF O RMATION 9 JANUARY 202 3 , 4 PM ET / 22 :00 CET MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance IRVINE, CA,...
MDxHealth SA press release ( NASDAQ: MDXH ): Q2Revenue of $6.9M. The Company ended the second quarter dated June 30, 2022, with a cash and cash equivalents balance of $40.0 million For further details see: MDxHealth SA reports Q2 results
Gainers: Allarity Therapeutics (ALLR) +13%. Better Therapeutics (BTTX) +19%. GeoVax Labs GOVX +10%. Insulet PODD +7%. MDxHealth (MDXH) +5%. Losers: INmune Bio (INMB) -29%. Liquidia (LQDA) -21%. TherapeuticsMD (TXMD) -19%. Aethlon Medical (AEMD) -14%....
News, Short Squeeze, Breakout and More Instantly...
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced the appoin...
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, today reported prelimi...
Mdxhealth to Present at Upcoming Investor Conferences IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 ( GlobeNewswire ) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, ...